Home > News > world-news Washington, Feb 26 : US officials are reportedly discussing new transportation agreements with five Central Asian countries that would enable the military to withdraw from Afghanistan without having to rely mainly on land routes through Pakistan. Continue reading
Editor's Choice Main Category: Obesity / Weight Loss / Fitness Also Included In: Regulatory Affairs / Drug Approvals Article Date: 18 Feb 2012 – 11:00 PST email to a friend printer friendly opinions Current Article Ratings: Patient / Public: 4 (1 votes) Healthcare Prof: The FDA has expressed concerned regarding obesity drug Qnexa – a combination of phentermine and topiramate – and what associations there may be between long-term usage and birth defect risks, as well as its impact on the heart. The Food and Drug Administration (FDA) is reviewing Qnexa again, after turning down its submission for approval two years ago (“FDA Turns Down Weight Loss Drug Qnexa, But Makers See Short Timeline For Approval”). Continue reading
A major fire at a Navarro Pharmacy in Little Havana sent a Miami firefighter to the hospital Tuesday morning, according to the Miami Fire Department. Capt Continue reading
SILVER may have just become even more precious. Continue reading
27-01-2012 20:04 As uploaded by real420daily This is a must-watch video featuring some of the top researchers on the healing effects of Cannabis (Marijuana) in it’s raw form, eaten or juiced. Eating raw cannabis as medicine, dietary essential: new research Cannabis is a dietary essential that helps all cell types function more effectively Continue reading
By Dan Dockstader on Jan 27, 2012 in News [1] [2] Governor Matt Mead, Secretary of State Max Maxfield and State Treasurer Joe Meyer appointed Jeff Vogel as the new Director of the Department of Audit. Vogel will serve a six-year term as director and the appointment requires confirmation by the Wyoming Senate. Vogel has been the head of the Division of Banking, in the Department of Audit, since 2002 Continue reading
Public release date: 26-Jan-2012 [ | E-mail [1] | Share [2] ] Contact: Paul Gallagher corporatecomms@strath.ac.uk 44-141-548-2370 University of Strathclyde [4] [3] A new system for delivering a drug to organ transplant patients, which could avoid the risk of harmful side effects, is being developed by scientists at the University of Strathclyde in Glasgow. The drug, cyclosporine (CsA), is widely used in transplant operations and helps prevent the patient's body rejecting the organ but it can cause adverse drug reactions, of which the most serious problems are kidney and liver damage, in the doses which are currently administered in the long term. Continue reading
DUBLIN–(BUSINESS WIRE)– Research and Markets ( http://www.researchandmarkets.com/research/f90328/hepatitis_c_hcv [1] ) has announced the addition of the ” Hepatitis C ( HCV ) Market Forecast & Drugs Pipeline Analysis to 2016″ report to their offering. Hepatitis C virus drug market is experiencing a dramatic near-term growth, by crossing US$ 6 Billion in 2011 and is expected to be more than double of its current figure by 2015. This robust growth will be driven primarily by the launch of novel premium-priced agents that will increase the size of the drug-treated population, mainly as a result of the re-treatment of prior non-responder patients. Continue reading
